Finally, there are also numerous changes in the chromatin landscape and epigenetic mechanisms regulating the biology of ERα-positive breast cancer that can orchestrate the resistance to breast cancer treatments (reviewed in [278]). Here, ESR1 is linked to breast carcinoma.